Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Price to Earnings (2014)

Updated

Vistagen Therapeutics' (VTGN) Price to Earnings was 4.96 for fiscal Q3 2015 (quarter ended Dec 31, 2014), up 36.7% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Price to Earnings (2014) Analysis & Trends

For FY2013 (ended Mar 31, 2013), Price to Earnings at Vistagen Therapeutics was 95.04.

  • Per Business Quant data, the three fiscal quarters before Q3 2015 came in at 3.62 (Q2 2015), 2.84 (Q1 2015) and 1.11 (Q4 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn
9 Gsk 193.54 Bn 176.38 Bn -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 148.70
Sep 30, 2014 108.74
Jun 30, 2014 85.09
Mar 31, 2014 33.43
API Access

Vistagen Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=VTGN&period=max&api_key=YOUR_API_KEY